Tue, Dec 16, 4:25 PM, Zacks
CR Bard (BCR) Faces Series of Lawuits - Analyst Blog
CR Bard Inc. (BCR) has been hit by a wave of product liability lawsuits over its faulty pelvic mesh products and defective vaginal-mesh implants, which could result in billions of dollars in damages.
Tue, Dec 16, 3:50 PM, Zacks
Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
On Dec 16, 2014, Zacks Investment Research upgraded Boston Scientific Corporation (BSX) to a Zacks Rank 2 (Buy).